http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115141256-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_573fd28b239863f33813bd0afadf8544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ecb211185330c5eada95232fcfe5fc9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K4-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
filingDate 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e3c4393c081a5f63d1642bd0f678622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37fe7892ffb47b09243542a887384aef
publicationDate 2022-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-115141256-A
titleOfInvention Antibacterial peptide for inhibiting novel coronavirus infection and use thereof
abstract The invention relates to the technical field of biomedicine, in particular to antibacterial peptides for inhibiting novel coronavirus infection and uses thereof, and in particular to an antibacterial peptide composition for inhibiting novel coronavirus infection. It is composed of other pharmaceutically acceptable excipients, carriers or auxiliary ingredients. The present invention also discloses the use of the antibacterial peptide and the composition thereof in inhibiting the infection of the novel coronavirus. disease. Compared with the prior art, the antimicrobial peptides and their compositions can effectively inhibit the new coronavirus, and have high safety, no hormones, and no antibiotics. Provide new ideas and scientific basis for infection and treatment of SARS‑CoV‑2 infection.
priorityDate 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1335626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15607819
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1335626
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID684371
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150903
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5IAB9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37228
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41340
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7016103
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8619802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415852845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6GXJ1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320081
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP82019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415827147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID386463
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8617527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID128837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8621378
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533319
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WTQ1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8622627
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID684371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426383573
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO88514

Total number of triples: 52.